Showing 1 - 15 results of 15 for search '"serosurvey"', query time: 0.06s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

    Prevalence of Antibody to Current Influenza Virus Strains in a 1992 Canadian Serosurvey and Crude Estimates of 1991–92 Season A/Beijing/353/89 Infections by John M Weber

    Published 1993-01-01
    “…Objectives: The annual influenza serosurvey was conducted to monitor influenza activity and gauge susceptibility to currently circulating and emerging influenza viruses.…”
    Get full text
    Article
  6. 6

    SARS-CoV-2 infection and antibody seroprevalence in routine surveillance patients, healthcare workers and general population in Kita region, Mali: an observational study 2020–2021... by Ulla Ashorn, Per Ashorn, Nigel Klein, Samba O Sow, Camilla Ducker, Elaine Cloutman-Green, Dagmar Alber, Fadima Cheick Haidara, Juho Luoma, Laura Adubra, Henry Badji, Fatoumata Diallo, Rikhard Ihamuotila, Owen Martell, Uma U Onwuchekwa, Oumar Samaké, Awa Traore, Kevin Wilson, Yue-Mei Fan

    Published 2022-06-01
    “…The monthly seroprevalence was around 10% from September to November 2020 and increased to over 40% from December 2020 to May 2021. For community serosurvey in December 2020, overall seroprevalence of SARS-CoV-2 antibodies was 27.7%. …”
    Get full text
    Article
  7. 7

    Geospatial distribution of Hepatitis E seroprevalence in Nepal, 2021. by Chulwoo Rhee, Amy Dighe, Nishan Katuwal, Haeun Cho, Ramzi Mraidi, Dipesh Tamrakar, Jacqueline KyungAh Lim, Nimesh Poudyal, Il-Yeon Park, Deok Ryun Kim, Ritu Amatya, Rajeev Shrestha, Andrew S Azman, Julia Lynch

    Published 2024-12-01
    “…We analyzed existing samples from a nationally representative serosurvey to describe the geospatial distribution and factors associated with HEV seroprevalence in Nepal, as a proxy for infection.…”
    Get full text
    Article
  8. 8

    Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 IgG in Juba, South Sudan, 20201 by Andrew, Baguma, Juma John, Hassen, Sheila, K. Baya, Joseph, F. Wamala

    Published 2021
    “…During August 10–September 11, 2020, we recruited 2,214 participants for a representative household-based cross-sectional serosurvey in Juba, South Sudan. We found 22.3% of participants had severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) receptor binding domain IgG titers above prepandemic levels. …”
    Get full text
    Article
  9. 9

    The omicron variant of SARS-CoV-2 drove broadly increased seroprevalence in a public university setting. by Ching-Wen Hou, Stacy Williams, Guillermo Trivino-Soto, Veronica Boyle, David Rainford, Selina Vicino, Mitch Magee, Yunro Chung, Joshua LaBaer, Vel Murugan

    Published 2025-01-01
    “…The seroprevalence of anti-receptor binding domain (RBD) antibodies was found to be 96.3% (95% CI 95.2-97.2%) compared to 88.2% (95% CI 86.1-90%) in our previous serosurvey. For anti-nucleocapsid (NC) antibodies, the seroprevalence was 39.1% (95% CI 36.6-41.7%) compared to 19.7% (95% CI 17.5-22.2%) earlier. …”
    Get full text
    Article
  10. 10

    Tracking Immunity: An Increased Number of COVID-19 Boosters Increases the Longevity of Anti-RBD and Anti-RBD-Neutralizing Antibodies by Ching-Wen Hou, Stacy Williams, Veronica Boyle, Alexa Roeder, Bradley Bobbett, Izamar Garcia, Giavanna Caruth, Mitch Magee, Yunro Chung, Douglas F. Lake, Joshua LaBaer, Vel Murugan

    Published 2025-01-01
    “…This study aimed to test our hypothesis that an increased number of exposures to SARS-CoV-2 RBD through vaccination/boosters/infection will increase SARS-CoV-2 antibody seroprevalence by increasing the longevity of anti-RBD and anti-RBD-neutralizing antibodies. Methods: A serosurvey was conducted at ASU from 30 January to 3 February 2023. …”
    Get full text
    Article
  11. 11
  12. 12
  13. 13

    Current challenges and implications for dengue, chikungunya and Zika seroprevalence studies worldwide: A scoping review. by Camille Fritzell, Dominique Rousset, Antoine Adde, Mirdad Kazanji, Maria D Van Kerkhove, Claude Flamand

    Published 2018-07-01
    “…Overall, dengue, chikungunya and Zika serosurveys followed the expansion of these arboviruses, but there remain gaps in their geographic distribution. …”
    Get full text
    Article
  14. 14

    Estimation of cause-specific mortality in Rakai, Uganda, using verbal autopsy 1999-2019 by Dorean Nabukalu, Júlia Almeida Calazans, Milly Marston, Clara Calvert, Hadijja Nakawooya, Brendah Nansereko, Robert Sekubugu, Gertrude Nakigozi, David Serwadda, Nelson Sewankambo, Godfrey Kigozi, Ronald H Gray, Fred Nalugoda, Fredrick Makumbi, Tom Lutalo, Jim Todd

    Published 2024-12-01
    “…Methodology Mortality information by cause, age, sex, and HIV status was recorded in the Rakai Community Cohort study using verbal autopsy interviews, HIV serosurveys, and residency data. We estimated the average number of years lived in adulthood. …”
    Get full text
    Article
  15. 15

    First detection and molecular characterization of porcine epidemic diarrhea virus (PEDV) in India: evidence of a new variant in Karnataka by Jagadish B. Hiremath, M. Swathi, R. Ramamoorthy, M. Shijili, Damini Sharma, Divakar Hemadri, H. B. Chethankumar, K. P. Suresh, Sharanagouda S. Patil, Shivasharanappa Nayakvadi, S. P. Satheesha, B. R. Shome, Baldev Raj Gulati

    Published 2025-02-01
    “…PEDV was confirmed in 17 of 21 fecal samples by amplifying the N, S, and M genes. Serosurveys showed seropositivity in Mandya (2.8%), Bengaluru Rural (6.6%), and Kolar (21.6%), districts indicating PEDV circulation in the state of Karnataka, India. …”
    Get full text
    Article